May 23, 2012
Hi doc: I have read news on the new integrase inhibitor, Dolutegravir, that according to the latest clinical trials, no integrase resistance has been found. If no resistances are found, wouldnt this compound be ideal to suppress the virus to undetectable levels? What would be your thoughts on Dolutegravir as possible Monotherapy?
Thanks for your comments.
| Response from Dr. Young
Hello and thanks for posting.
Dolutegravir is an experimental HIV integrase inhibitor in phase III clinical trials. It looks to be a very potent, and very well tolerated medication.
I'm afraid that you've probably misread the literature. Resistance to dolutegravir is described; it's interesting that in the phase II clinical trial of treatment naive persons, those who started on 50 mg daily dosing did not have any treatment failure to date.
I would not think that any current HIV integrase inhibitor would be suitable as a monotherapy for HIV.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.